Ipraalox

Pantoprazole, the active ingredient in Ipraalox, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Ipraalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: facilitates mucosal repair and reduces further acid injury. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours. - Peptic ulcer disease: supports ulcer healing by maintaining a low‑acid environment. - Helicobacter pylori eradication regimens (as adjunct): enhances the effectiveness of antibiotic‑based therapy.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools, often transient. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Clostridioides difficile infection: persistent diarrhoea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: signs of hepatic stress. - Bone fractures (with long‑term use): increased risk of hip, wrist or spine fractures.

When using Pantoprazole, consider the following precautions: - Assess renal function: dose adjustment may be needed in severe impairment. - Monitor magnesium levels: prolonged therapy can lead to hypomagnesemia. - Evaluate for H. pylori infection: may require combination therapy. - Use cautiously in patients with liver disease: monitor hepatic function. - Avoid abrupt discontinuation: may cause rebound acid hypersecretion. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Pantoprazole can interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Antifungal agents (e.g., itraconazole, ketoconazole): reduced absorption due to increased gastric pH. - HIV protease inhibitors (e.g., atazanavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: possible increase in serum concentration. - Oral contraceptives: reduced efficacy may occur.